SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-028942
Filing Date
2021-05-20
Accepted
2021-05-20 06:02:39
Documents
12
Period of Report
2021-05-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20210519.htm   iXBRL 8-K 44175
  Complete submission text file 0001564590-21-028942.txt   176541

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA onct-20210519.xsd EX-101.SCH 5780
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20210519_lab.xml EX-101.LAB 19471
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20210519_pre.xml EX-101.PRE 11635
5 EXTRACTED XBRL INSTANCE DOCUMENT onct-8k_20210519_htm.xml XML 3570
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 21942261
SIC: 2834 Pharmaceutical Preparations